Celecoxib (SC-58635): Mechanism of Action

Celecoxib (SC-58635) MOA:Targeting COX-2/PGE2 Signaling Pathway for Oncology

🎯 check Celecoxib (SC-58635) product page

Celecoxib (SC-58635) is a potent, selective COX-2 inhibitor. It affects COX-2/PGE2, PI3K/AKT, and NF-κB signaling pathways by blocking COX-2 enzymatic activity and reducing PGE2 production, thereby inhibiting cancer cell proliferation, migration, and angiogenesis, and promoting apoptosis.

Primary Applications and Mechanism of Action